EdgeMarket › What Camber Capital Management Lp reported owning
What Camber Capital Management Lp reported owning
As filed on Form 13F for the quarter ending 2025-06-30, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
1.1BPositions
25Quarter
2025-06-30Shown below
23largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| ZBH ZIMMER BIOMET HOLDINGS, INC. | 91.2M | 8.6% | 1.0M | 100.98 | -4.5% |
| BAX BAXTER INTERNATIONAL INC | 86.3M | 8.1% | 2.9M | 26.34 | +8.5% |
| HUM HUMANA INC | 73.3M | 6.9% | 300.0K | 378.88 | +30.6% |
| CVS CVS HEALTH Corp | 72.4M | 6.8% | 1.1M | 93.02 | +31.3% |
| GMED GLOBUS MEDICAL INC | 47.2M | 4.4% | 800.0K | 86.91 | +43.1% |
| ICLR ICON PLC | 43.6M | 4.1% | 300.0K | 172.23 | -4.4% |
| ASND Ascendis Pharma A/S | 43.1M | 4.1% | 250.0K | 253.29 | +31.4% |
| MRK Merck & Co., Inc. | 39.6M | 3.7% | 500.0K | 152.55 | +80.2% |
| PFE PFIZER INC | 36.4M | 3.4% | 1.5M | 28.07 | +10.6% |
| BMRN BIOMARIN PHARMACEUTICAL INC | 33.0M | 3.1% | 600.0K | 66.70 | +15.1% |
| UNH UNITEDHEALTH GROUP INC | 31.2M | 2.9% | 100.0K | 390.11 | +30.1% |
| VTRS Viatris Inc | 24.6M | 2.3% | 2.8M | 16.32 | +53.2% |
| BKD Brookdale Senior Living Inc. | 15.0M | 1.4% | 2.1M | 11.80 | +61.4% |
| unmapped CUSIP 98888T107 | 15.0M | 1.4% | 1.6M | — | — |
| unmapped CUSIP 03753U106 | 14.7M | 1.4% | 850.0K | — | — |
| MYGN MYRIAD GENETICS INC | 10.6M | 1.0% | 2.0M | 3.20 | -42.1% |
| EVH Evolent Health, Inc. | 9.6M | 0.9% | 850.0K | 4.74 | -47.1% |
| CON Concentra Group Holdings Parent, Inc. | 8.2M | 0.8% | 400.0K | 35.00 | +51.3% |
| INGN Inogen Inc | 6.9M | 0.6% | 975.0K | 5.61 | -23.9% |
| DNLI Denali Therapeutics Inc. | 5.6M | 0.5% | 400.0K | 24.92 | +71.7% |
| TBPH Theravance Biopharma, Inc. | 5.0M | 0.5% | 450.0K | 17.01 | +27.0% |
| ANAB ANAPTYSBIO, INC | 2.8M | 0.3% | 125.0K | 57.74 | +186.6% |
| OSUR ORASURE TECHNOLOGIES INC | 2.7M | 0.3% | 900.0K | 3.88 | +33.8% |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →